Combined anti-angiogenic and cytotoxic treatment of a solid tumour: in silico investigation of a xenograft animal model’s digital twin - Laboratoire des Sciences des Procédés et des Matériaux Accéder directement au contenu
Article Dans Une Revue (Data Paper) Journal of Theoretical Biology Année : 2022

Combined anti-angiogenic and cytotoxic treatment of a solid tumour: in silico investigation of a xenograft animal model’s digital twin

Eleftherios Ioannou
  • Fonction : Auteur
Nicolas Aristokleous
  • Fonction : Auteur
Charalambos Anastassiou
Vasileios Vavourakis
  • Fonction : Auteur

Résumé

Anti-angiogenic (AA) treatments have received significant research interest due to the key role of an-giogenesis in cancer progression. AA agents can have a strong effect on cancer regression, by blockingnew vessels and reducing the density of the existing vasculature. Moreover, in a process termed vascularnormalisation, AA drugs can improve the abnormal structure and function of the tumour vasculature,enhancing the delivery of chemotherapeutics to the tumour site. Despite their promising potential, animproved understanding of AA treatments is necessary to optimise their administration as a monotherapy orin combination with other cancer treatments. In this work we present anin silicomultiscale cancer modelwhich is used to systematically interrogate the role of individual mechanisms of action of AA drugs intumour regression. Focus is placed on the reduction of vascular density and on vascular normalisation througha parametric study, which are considered either as monotherapies or in combination with conventional/metronomic chemotherapy. The model is specified to data from a mammary carcinoma xenograft in im-munodeficient mice, to enhance the physiological relevance of model predictions. Our results suggest thatconventional chemotherapy might be more beneficial when combined with AA treatments, hindering tumourgrowth without causing excessive damage on healthy tissue. Notably, metronomic chemotherapy has shownsignificant potential in stopping tumour growth with minimal toxicity, even as a monotherapy. Our findingsunderpin the potential of ourin silicoframework for non-invasive and cost-effective evaluation of treatmentstrategies, which can enhance our understanding of combined therapeutic strategies and contribute towardsimproving cancer treatment management.
Fichier non déposé

Dates et versions

hal-04041222 , version 1 (22-03-2023)

Identifiants

Citer

Myrianthi Hadjicharalambous, Eleftherios Ioannou, Nicolas Aristokleous, Kristaq Gazeli, Charalambos Anastassiou, et al.. Combined anti-angiogenic and cytotoxic treatment of a solid tumour: in silico investigation of a xenograft animal model’s digital twin. Journal of Theoretical Biology, 2022, 553, pp.111246. ⟨10.1016/j.jtbi.2022.111246⟩. ⟨hal-04041222⟩
8 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More